drugset / Trial / NCT01014247
Influence of Moxifloxacin on QTc Interval in Healthy Subjects for Positive Control Validation
RandomizedCrossoverTriple-blindTreatment
Summary
The aim of this study is to investigate the effect of moxifloxacin on the QT interval in order to gain information on the validity of results that will be collected during another clinical study testing riociguat in patients with pulmonary arterial hypertension (PATENT-1 study).
Timeline
- Start
- 2009-11
- Primary completion
- 2010-06
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Moxifloxacin | Small molecule | 400 mg | — |
Indications
No indication recorded.